Topamax birth defects (part 2)

April 26, 2011 @ 03:37 PM -- by

Texas Topamax birth defects lawyers are also aware of other Food & Drug Administration problems with Topamax and its makers. For example, two Johnson & Johnson ("J&J") subsidiaries, Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals Inc, were accused by the United States Department of Justice of promoting Topamax in an "off-label" way to doctors for patently unapproved purposes. Essentially, the government held that Ortho-McNeil had hired speakers to promote the off-label use of Topamax. The case was settled, and the makers of the brand name version of Topamax plead guilty. They also paid a $6,140,000.00 criminal fine, as well as $75,370,000.00 for violating the False Claims Act.  

Topamax birth defects (part 1)

April 25, 2011 @ 05:56 PM -- by

As a Texas Topamax birth defects lawyer, I am following the drug and its various problems closely. Topamax, which is made by Ortho-McNeil Janseen Pharmacueticals Inc., has been used to treat many issues. Topamax (which is generically called "topiramate") treats epilepsy in both children and adults. The drug was originally marketed as an anticonvulsant. Topamax is also used to treat children with Lennox-Gastaut syndrome, which is a disorder that causes seizures and developmental delay. Topamax has been approved by the United States Food and Drug Administration (FDA) for the prevention of migraines. Psychiatrists have used Topamax and its generic to treat bipolar disorder, as well as to augment psychotrophics. However, one review in 2006 found insufficient evidence for the drug’s use with bipolar illness. Topamax has also been investigated for use in treating obesity and alcoholism and obesity.